# Humacyte's HAV for Femoro-Popliteal Bypass in Patients With PAD

> **NCT02887859** · PHASE2 · COMPLETED · sponsor: **Humacyte, Inc.** · enrollment: 15 (actual)

## Conditions studied

- Peripheral Artery Disease

## Interventions

- **BIOLOGICAL:** Human Acellular Vessel (HAV)

## Key facts

- **NCT ID:** NCT02887859
- **Lead sponsor:** Humacyte, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-20
- **Primary completion:** 2020-12
- **Final completion:** 2023-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02887859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02887859, "Humacyte's HAV for Femoro-Popliteal Bypass in Patients With PAD". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02887859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*